Cryoport Inc (CYRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cryoport Inc (CYRX) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.73 Million) by net assets ($494.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CYRX defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Cryoport Inc - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Cryoport Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cryoport Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryoport Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Placoplatre SA
PA:MLPLC
|
N/A |
|
BGT Group Co. Ltd.
SHE:300774
|
N/A |
|
Merida Industry Co Ltd
TW:9914
|
-0.009x |
|
Shandong Huatai Paper Industry Shareholding Co Ltd
SHG:600308
|
0.023x |
|
GCM Grosvenor Inc
NASDAQ:GCMG
|
0.423x |
|
Chengdu Bright Eye Hospital Co. Ltd.
SHE:301239
|
N/A |
|
Hi target Navigation Tech Co
SHE:300177
|
0.010x |
|
SunCoke Energy Inc
NYSE:SXC
|
0.013x |
Annual Cash Flow Conversion Efficiency for Cryoport Inc (2004–2025)
The table below shows the annual cash flow conversion efficiency of Cryoport Inc from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Cryoport Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $502.64 Million | $-8.58 Million | -0.017x | +57.97% |
| 2024-12-31 | $401.90 Million | $-16.32 Million | -0.041x | -2523.72% |
| 2023-12-31 | $489.02 Million | $-757.00K | -0.002x | +53.52% |
| 2022-12-31 | $555.84 Million | $-1.85 Million | -0.003x | -126.30% |
| 2021-12-31 | $641.83 Million | $8.13 Million | 0.013x | +132.59% |
| 2020-12-31 | $382.70 Million | $-14.87 Million | -0.039x | -270.50% |
| 2019-12-31 | $126.28 Million | $-1.32 Million | -0.010x | +87.94% |
| 2018-12-31 | $38.55 Million | $-3.35 Million | -0.087x | +56.59% |
| 2017-12-31 | $17.89 Million | $-3.58 Million | -0.200x | +80.10% |
| 2016-12-31 | $5.68 Million | $-5.72 Million | -1.007x | +20.32% |
| 2015-12-31 | $4.99 Million | $-6.31 Million | -1.264x | -112.74% |
| 2014-12-31 | $-416.30K | $-4.13 Million | 9.915x | +421.60% |
| 2013-12-31 | $-2.30 Million | $-4.38 Million | 1.901x | -18.04% |
| 2012-12-31 | $-2.06 Million | $-4.79 Million | 2.319x | +227.57% |
| 2011-12-31 | $3.73 Million | $-6.78 Million | -1.818x | -124.76% |
| 2010-12-31 | $5.95 Million | $-4.81 Million | -0.809x | -125.93% |
| 2009-12-31 | $-914.58K | $-2.85 Million | 3.120x | +344.34% |
| 2008-12-31 | $-3.68 Million | $-2.59 Million | 0.702x | +126.17% |
| 2007-12-31 | $-2.29 Million | $-710.26K | 0.310x | -47.33% |
| 2006-12-31 | $-1.96 Million | $-1.16 Million | 0.589x | +9.63% |
| 2005-12-31 | $-2.15 Million | $-1.16 Million | 0.538x | -37.68% |
| 2004-12-31 | $-1.18 Million | $-1.02 Million | 0.863x | -- |
About Cryoport Inc
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic … Read more